| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 04/19/2007 | CA2625611A1 Imidazo benzodiazepine derivatives |
| 04/19/2007 | CA2625207A1 Compounds comprising short aminoalcohol chains and metal complexes for medical imaging |
| 04/19/2007 | CA2625109A1 Pyrrolopyrimidine derivatives as syk inhibitors |
| 04/19/2007 | CA2624902A1 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 04/19/2007 | CA2624829A1 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 04/19/2007 | CA2624826A1 Pyrazolopyrimidines as protein kinase inhibitors |
| 04/19/2007 | CA2624822A1 Pyrazolopyrimidines as cyclin dependent kinase inhibitors for the treatment of cancer |
| 04/19/2007 | CA2624519A1 Pyrazolo [1,5-a] pyrimidines as protein kinase inhibitors |
| 04/19/2007 | CA2624500A1 Pyrazolopyrimidines as protein kinase inhibitors |
| 04/19/2007 | CA2624333A1 Compounds and methods for inhibiting hepatitis c viral replication |
| 04/18/2007 | EP1773837A2 Pyrrolotriazine kinase inhibitors |
| 04/18/2007 | EP1773836A1 Pyrrolopyrimidine derivatives useful in cancer treatment |
| 04/18/2007 | EP1773833A2 Pyrrolo(oxo)quinolines as 5ht ligands |
| 04/18/2007 | EP1773831A1 Antibacterial agents |
| 04/18/2007 | EP1773826A2 C-met modulators and method of use |
| 04/18/2007 | EP1773822A2 Heterocyclyls as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders |
| 04/18/2007 | EP1773821A2 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders |
| 04/18/2007 | EP1773791A1 Pyrrolotriazine compounds |
| 04/18/2007 | EP1773348A2 Tetrapeptide analogs |
| 04/18/2007 | EP1773345A2 Non-imidazole tertiary amines as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other cns disorders |
| 04/18/2007 | EP1773343A1 Antibacterial agents |
| 04/18/2007 | EP1455792B1 Ureas of 2-aminobenzothiazoles as adenosine modulators |
| 04/18/2007 | EP1451161B1 Imidazopyridines, pyrimidines and triazines for enhancing cognition as gaba-a alpha 5 receptor subtype ligands |
| 04/18/2007 | EP1353662B1 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors |
| 04/18/2007 | EP1326613B2 Use of substituted imidazo 1,2-a|pyridine-, imidazo ¬1,2-a|pyrimidine and imidazo ¬1,2-a|pyrazine-3-yl-amine derivatives for producing nos-inhibiting medicaments |
| 04/18/2007 | EP1028940B1 Process to produce oxazolidinones |
| 04/18/2007 | CN1950374A Tetraazabenzo[e]azulene derivatives and analogs thereof |
| 04/18/2007 | CN1950373A Processes of preparing glycolurils and cucurbiturils using microwave |
| 04/18/2007 | CN1950358A Novel gamma secretase inhibitors |
| 04/18/2007 | CN1950082A Bicyclic and bridged nitrogen heterocycles |
| 04/18/2007 | CN1948314A 8-arylamine-3H-imidazole [4,5-g] quinazoline derivatives and its solid phase synthesis method |
| 04/18/2007 | CN1948313A Preparation method of tiemoazoleamine-8-carboxylic acid water soluble derivative, anticancer activity and application in preparing anticancer medicine |
| 04/18/2007 | CN1948310A 3 position substituted mesoazalene compounds and high efficiency synthesis method |
| 04/18/2007 | CN1310918C Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 04/18/2007 | CN1310916C Hetero-bicyclic compounds |
| 04/18/2007 | CN1310642C Methods and compositions to enhance white blood cell count |
| 04/17/2007 | US7205408 Therapy for bacteria infections in mammals |
| 04/17/2007 | US7205316 Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands |
| 04/17/2007 | US7205310 inflammatory conditions such as multiple sclerosis |
| 04/17/2007 | US7205308 Trisubstituted 7-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 04/17/2007 | US7205305 Inhibitors of p38 |
| 04/17/2007 | US7205304 medicine to inhibit proliferative conditions, such as cancer and psoriasis |
| 04/17/2007 | US7205299 Indole derivatives having an apoptosis-inducing effect |
| 04/17/2007 | US7205291 Carbapenem compounds |
| 04/17/2007 | CA2386799C Fused cycloheptane and fused azacycloheptane compounds and their as integrin receptor antagonists |
| 04/17/2007 | CA2350073C Ccr5 modulators |
| 04/17/2007 | CA2190765C Novel potent inducers of terminal differentiation and methods of use thereof |
| 04/17/2007 | CA2141589C Antiretroviral enantiomeric nucleotide analogs |
| 04/17/2007 | CA2106882C Azaquinoxalines, processes for their preparation and their use |
| 04/12/2007 | WO2007041712A1 Pyrazolopyrimidines as protein kinase inhibitors |
| 04/12/2007 | WO2007041130A2 Deazapurines useful as inhibitors of janus kinases |
| 04/12/2007 | WO2007040650A2 Apoptosis promoters |
| 04/12/2007 | WO2007040506A1 High-purity texaphyrin metal complexes |
| 04/12/2007 | WO2007040435A1 Novel 5,6-dihydropyrazolo[3,4-e] [l,4]diazepin-4 (ih) -one derivatives for the treatment of asthma and chronic obstructive pulmonary disease. |
| 04/12/2007 | WO2007039752A1 Alkyl 4- [4- (5-oxo-2, 3, 5, 11a-tetrahyd0-5h-pyrr0l0 [2, 1-c] [1, 4] benzodiazepine-8-yloxy) -butyrylamino]-1h-pyrrole-2-carboxylate derivatives and related compounds for the treatment of a proliferative disease |
| 04/12/2007 | WO2007039439A1 Oxadiazolyl pyrazolo-pyrimidines as mglur2 antagonists |
| 04/12/2007 | WO2007039286A1 Tetrahydro-pyrrolizinone compounds as lfa-i mediators |
| 04/12/2007 | WO2007039285A1 Bicyclic aromatic compounds useful as inhibitors of mitogen-activated protein kinase-activated protein kinase-2 |
| 04/12/2007 | WO2007039264A1 Pyrazolo [1, 5 -alpha] pyrimidinyl derivatives useful as corticotropin-releasing factor (crf) receptor antagonists |
| 04/12/2007 | WO2007023115A3 P38 map kinase inhibitors and methods for using the same |
| 04/12/2007 | WO2007023115A2 P38 map kinase inhibitors and methods for using the same |
| 04/12/2007 | WO2007011759A3 Inhibitors of mitotic kinesin |
| 04/12/2007 | WO2006138230A3 The preparation and use of protease inhibitors |
| 04/12/2007 | WO2006124813A3 Substituted 7, 8-dihydro-1h-pyrimido [4,5-b] [1,4] diazepin-4-amines as?kinase inhibitors |
| 04/12/2007 | WO2005075460A3 Pyrrolopyrimidine derivatives for treating proliferative diseases |
| 04/12/2007 | US20070083045 Dihydroxypyrimidine carboxamide inhibitors of HIV integrase |
| 04/12/2007 | US20070083044 checkpoint kinase inhibitors; for treating and preventing proliferative diseases such as cancer, inflammation and arthritis, neurodegenerative diseases such Alzheimer's disease, cardiovascular diseases, viral diseases and fungal diseases |
| 04/12/2007 | US20070082920 NAD+-dependent DNA ligase inhibitors |
| 04/12/2007 | US20070082909 Acyclic Ikur inhibitors |
| 04/12/2007 | US20070082908 Bicycle pyrazole derivative |
| 04/12/2007 | US20070082902 cancer, inflammation and arthritis, neurodegenerative diseases such Alzheimer's disease, cardiovascular diseases, viral diseases and fungal diseases |
| 04/12/2007 | US20070082901 Pyrazolopyrimidines as protein kinase inhibitors |
| 04/12/2007 | US20070082891 Novel pyrrolo[2,1-C] [1,4] benzodiazepine compounds and processes for the preparation thereof |
| 04/12/2007 | US20070082890 Substituted imidazo-[1,5-a][1,2,4]triazolo[1,5-d][1,4] benzodiazepine derivatives |
| 04/12/2007 | US20070082884 Selective serine/threonine kinase inhibitors |
| 04/12/2007 | US20070082874 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 04/12/2007 | US20070079729 6,13-Dihydropyrazino[2,3-b:5,6-b]diquinoxaline derivatives for use in ink jet printers; particularly good ozone fastness |
| 04/12/2007 | CA2624882A1 Pyrazolopyrimidines as protein kinase inhibitors |
| 04/12/2007 | CA2624699A1 Pyrazolo [1,5-alpha] pyrimidinyl derivatives useful as corticotropin-releasing factor (crf) receptor antagonists |
| 04/12/2007 | CA2624488A1 Tetrahydro-pyrrolizinone compounds as lfa-i mediators |
| 04/12/2007 | CA2624468A1 Bicyclic aromatic compounds useful as inhibitors of mitogen-activated protein kinase-activated protein kinase-2 |
| 04/12/2007 | CA2623721A1 Oxadiazolyl pyrazolo-pyrimidines as mglur2 antagonists |
| 04/12/2007 | CA2623334A1 High-purity texaphyrin metal complexes |
| 04/12/2007 | CA2623032A1 Deazapurines useful as inhibitors of janus kinases |
| 04/11/2007 | EP1772454A1 Nitrogenous fused bicyclic compound |
| 04/11/2007 | EP1772453A1 Process to produce Oxazolidinones |
| 04/11/2007 | EP1771452A2 Inhibitors of 5'-methylthioadenosine phosphorylase and 5'methylthioadenosine/s-adenosylhomocysteine nucleosidase |
| 04/11/2007 | EP1771451A2 (1s,5s)-3-(5,6-dichloropyridin-3-yl)-3,6-diazabicyclo[3.2.0]heptane benzenesulfonate |
| 04/11/2007 | EP1771450A2 Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase |
| 04/11/2007 | EP1771448A1 Azaindole carboxamides |
| 04/11/2007 | EP1771421A1 N-hydroxyamide derivatives and use thereof |
| 04/11/2007 | EP1771177A2 Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors |
| 04/11/2007 | EP1771176A2 Methods and compositions |
| 04/11/2007 | EP1399444B1 Novel heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as anti-bacterial agents |
| 04/11/2007 | EP1147093B1 Substituted bicyclic derivatives useful as anticancer agents |
| 04/11/2007 | CN1946726A Derivatives of 1,4-diazabicyclo[3.2.1]octanecarboxamide, preparation method thereof and use of same in therapeutics |
| 04/11/2007 | CN1946725A Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 04/11/2007 | CN1946293A Pyrazolopyrimidines for combatting unwanted microorganisms |
| 04/11/2007 | CN1944447A Synthetic method for metal porphyrin |
| 04/11/2007 | CN1944434A Method for synthesizing porphyrin and metal porphyrin |